Bharat Biotech to expand production capacity, 70 crore doses of Covaxin annually

Indian vaccine manufacturer Bharat Biotech on Tuesday announced expansion of its vaccine production capacity. The firm will now produce 700 million or 70 crore doses of Covaxin a year.

The decision to scale-up the production capacity of the Covaxin comes at a time



when India is witnessing a shortage of Covid-19 vaccines as the country battles the second wave of pandemic.

The Bharat Biotech said manufacturing scale has been ramped up and is being carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore.